Rutgers Medical School, Piscataway, New Jersey.
Ann Dyslexia. 1986 Jan;36(1):118-37. doi: 10.1007/BF02648025.
A review is presented of controlled studies using intensive teaching intervention to improve dyslexics' reading ability. The results of eight controlled studies reveal only one showing the superiority of teaching. Taking this as a background, the work on Nootropics is reviewed. Both animal and clinical work with Piracetam (the first of the Nootropics) seems to indicate that this medication lacks significant or serious side effects and appears to promote memory and learning. Many double-blind studies of Piracetam have now been conducted on dyslexic children. These studies suggest that Piracetam improves the reading ability of dyslexics. In addition electrophysiological studies support the notion that Piracetam may be "left hemisphere active." Such encouraging trends will doubtless lead to further research in this interesting area.
本文回顾了使用强化教学干预来提高阅读障碍者阅读能力的对照研究。八项对照研究的结果仅显示出一种教学方法具有优越性。在此背景下，对益智药的研究进行了回顾。吡拉西坦（益智药的第一种）的动物和临床研究似乎表明，这种药物没有明显或严重的副作用，并且似乎可以促进记忆和学习。现在已经对阅读障碍儿童进行了许多吡拉西坦的双盲研究。这些研究表明，吡拉西坦可以提高阅读障碍者的阅读能力。此外，电生理学研究支持吡拉西坦可能具有“左半球活性”的观点。这些令人鼓舞的趋势无疑将导致在这一有趣领域进行进一步的研究。
